Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopa
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Biostatistical Analysis.
1975 • 10,200 citations
New Method for Calculating the Intrinsic Absorption Rate of Drugs
1968 • 453 citations
Hypertension: Mechanisms and Management
1978 • 270 citations
Studies on the Metabolism and Mechanism of Action of Methyldopa
1963 • 123 citations
Pharmacokinetics of methyldopa in man.
1976 • 74 citations
THE METABOLISM OF METHYLDOPA IN HYPERTENSIVE HUMAN SUBJECTS.
1964 • 68 citations
Symbols in pharmacokinetics
1980 • 66 citations
The metabolism of14C-labelled α-methyldopa in normal and hypertensive human subjects
1972 • 52 citations
Synthesis and antihypertensive activity of some ester progenitors of methyldopa
1978 • 51 citations
Novel Method for Bioavailability Assessment
1973 • 49 citations
Testing the Homogeneity of Variances in a Two-Way Classification
1969 • 41 citations
Pharmacokinetics of methyldopa in healthy man
1977 • 28 citations
Evaluation of succinimidoethyl and pivaloyloxyethyl esters as progenitors of methyldopa in man, rhesus monkey, dog, and rat.
1978 • 27 citations
Potential source of error in absorption rate calculations
1975 • 24 citations
Kinetic Parameter Estimation by Numerical Algorithms and Multiple Linear Regression: Theoretical
1977 • 10 citations
Pharmacokinetics of Methsuximide and a Major Metabolite in Dogs
1977 • 6 citations
Kinetic Parameter Estimation by Numerical Algorithms and Multiple Linear Regression: Application to Pharmacokinetics
1979 • 6 citations